Marital Status Is An Independent Predictor Of Survival For Patients Undergoing Definitive Chemoradiation For Stage Iii Non-small Cell Lung Cancer (nsclc)

被引:0
|
作者
Nichols, E. M. [1 ]
Liriano, M. [1 ]
Morris, C. G. [2 ]
Burrows, W. [1 ]
Battafarano, R. [1 ]
Garofalo, M. [1 ]
Turner, M. [1 ]
Suntharalingam, M. [1 ]
Edelman, M. J. [1 ]
Feigenberg, S. J. [1 ]
机构
[1] Univ Maryland Hosp, Baltimore, MD 21201 USA
[2] Univ Florida, Gainesville, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S274 / S274
页数:1
相关论文
共 50 条
  • [31] The interaction between smoking status and disease stage on non-small cell lung cancer (NSCLC) survival
    Horgan, A. M.
    Wang, Y. V.
    Shepherd, F. A.
    Brenner, D.
    Knox, J. J.
    McLaughlin, J.
    Liu, G.
    Hung, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Evaluating the prognostic significance of significant weight loss in patients with stage III non-small cell lung cancer (NSCLC) undergoing definitive chemoradiation (CRT) after FOG-PET staging.
    Senko, Clare
    Moore, Julie
    Hay, Karen
    Lwin, Zarnie
    Pratt, Gary
    Fong, Kwun
    Hughes, Brett Gordon Maxwell
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Comprehensive Analysis of Dosimetric Predictors of Overall Survival for Stage III Non-Small Cell Lung Cancer (NSCLC) Treated With Definitive Radiation Therapy
    Speirs, C. K.
    Rehman, S.
    Molotievschi, A.
    Velez, M. A.
    DeWees, T. A.
    Mullen, D.
    Fergus, S.
    Bradley, J. D.
    Robinson, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S667 - S667
  • [34] Gross Target Volume as the Predictor for the Overall Survival for Stage III Non-Small Cell Lung Cancer
    Sun, J.
    Zhang, X.
    Chang, J. Y.
    Gomez, D.
    Jiang, S.
    Wang, P.
    Yuan, Z.
    Zhao, L.
    Wang, L.
    Hui, Z.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S642 - S643
  • [35] Ethnic difference in chemoradiation-induced esophagitis in unresectable stage III non-small cell lung cancer (NSCLC).
    Komiya, Takefumi
    Palla, Shana L.
    Wang, Fen
    Perez, Raymond P.
    Huang, Chao Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Gross Target Volume as the Predictor for the Overall Survival for Stage III Non-Small Cell Lung Cancer
    Sun, J.
    Zhang, X.
    Chang, J. Y.
    Gomez, D.
    Jiang, S.
    Wang, P.
    Yuan, Z.
    Zhao, L.
    Wang, L.
    Hui, Z.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S21 - S21
  • [37] Evaluation of platinum pharmacogenomics and response, toxicity and survival in patients with stage III non-small cell lung cancer treated with chemoradiation
    Vaena, Daniel A.
    Murry, Daryl J.
    Clamon, Gerald
    Etscheid, Carlene
    Bhatia, Sundershan
    Al Omari, Amal
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3569S - 3570S
  • [38] Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
    Soussi, Ghassen
    Racil, Hajer
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Zidi, Asma
    Ayadi, Aida
    Chaouch, Nawel
    Chabbou, Abdellatif
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation
    Kim, Yong-Hyub
    Ahn, Sung-Ja
    Kim, Young-Chul
    Kim, Kyu-Sik
    Oh, In-Jae
    Ban, Hee-Jung
    Chung, Woong-Ki
    Nam, Taek-Keun
    Yoon, Mee Sun
    Jeong, Jae-Uk
    Song, Ju-Young
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (02) : 144 - 151
  • [40] Preoperative survivin, ERCC1, and PTEN expression in stage III non-small cell lung cancer (NSCLC) patients (pts) treated with neoadjuvant and definitive chemoradiation and association with overall survival (OS)
    Batus, Marta
    Fidler, Mary J.
    Walters, Kelly Kaiser
    Pool, Mark
    Mahon, Brett
    Basu, Sanjib
    Borgia, Jeffrey Allen
    Sher, David
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)